|
|
 Previous Article | Table of Contents | Next Article 
A Factor V Genetic Component Differing From Factor V R506Q Contributes to the Activated Protein C Resistance Phenotype
F. Bernardi,
E.M. Faioni,
E. Castoldi,
B. Lunghi,
G. Castaman,
E. Sacchi, and
P.M. Mannucci
From the Dipartimento di Biochimica e Biologia Molecolare, Università di Ferrara, Ferrara, Italy; the Hemophilia and Thrombosis Center A. Bianchi Bonomi, IRCCS Maggiore Hospital and University of Milano, Milan, Italy; the Divisione di Ematologia-CRS Malattie Emorragiche e Trombotiche, Osp. S. Bortolo, Vicenza, Italy.
Factor V gene polymorphisms were investigated to detect components that may contribute to the activated protein C (APC) resistance phenotype in patients with venous thromboembolism. A specific factor V gene haplotype (HR2) was defined by six polymorphisms and its frequency was found to be similar in normal subjects coming from Italy (0.08), India (0.1), and Somalia (0.08), indicating that it was originated by ancestral mutational events. The relationship between the distribution of normalized APC ratios obtained with the functional assay and haplotype frequency was analyzed in patients heterozygous for factor V R506Q (factor V Leiden). The HR2 haplotype was significantly more frequent in patients with ratios below the 15th percentile than in those with higher ratios or in normal controls. Moreover, the study of 10 patients with APC resistance in the absence of the factor V R506Q mutation showed a 50-fold higher frequency of HR2 homozygotes. The HR2 haplotype was associated with significantly lower APC ratios both in patients with venous thromboembolism and in age- and sex-matched controls. However, the two groups showed similar HR2 haplotype frequencies. Plasma mixing experiments showed that an artificially created double heterozygote for the factor V R506Q mutation and the HR2 haplotype had an APC ratio lower than that expected for a simple R506Q heterozygote. Time-course experiments evaluating the decay of factor V in plasma showed the normal stability of the molecule encoded by the factor V gene marked by the HR2 haplotype, which ruled out the presence of a pseudo-homozygous APC resistance mechanism. Our results provide new insights into the presence of factor V genetic components other than the factor V R506Q that are able to contribute to the APC resistance phenotype in patients with venous thromboembolism.
Blood, Vol. 90 No. 4 (August 15), 1997:
pp. 1552-1557
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
F. H. Herrmann, K. Wulff, R. Strey, A. Siegemund, J. Astermark, S. Schulman, and for the International Greifswald Registry of FVII
Variability of clinical manifestation of factor VII-deficiency in homozygous and heterozygous subjects of the European F7 gene mutation A294V
Haematologica,
August 1, 2008;
93(8):
1273 - 1275.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Dawood, R. Mountford, R. Farquharson, and S. Quenby
Genetic polymorphisms on the factor V gene in women with recurrent miscarriage and acquired APCR
Hum. Reprod.,
September 1, 2007;
22(9):
2546 - 2553.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. L. Bick
Hereditary and Acquired Thrombophilic Disorders
Clinical and Applied Thrombosis/Hemostasis,
April 1, 2006;
12(2):
125 - 135.
[PDF]
|
|
|
|
|
|
|
B. S. Donahue
The Response to Activated Protein C After Cardiopulmonary Bypass: Impact of Factor V Leiden
Anesth. Analg.,
December 1, 2004;
99(6):
1598 - 1603.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. S. Donahue
Factor V Leiden and Perioperative Risk
Anesth. Analg.,
June 1, 2004;
98(6):
1623 - 1634.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Castoldi, J. M. Brugge, G. A. F. Nicolaes, D. Girelli, G. Tans, and J. Rosing
Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations
Blood,
June 1, 2004;
103(11):
4173 - 4179.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. A. Al-Allawi, J. M.S. Jubrael, and F. A. Hilmi
Factor V Leiden in Blood Donors in Baghdad (Iraq)
Clin. Chem.,
March 1, 2004;
50(3):
677 - 678.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Scanavini, D. Girelli, B. Lunghi, N. Martinelli, C. Legnani, M. Pinotti, G. Palareti, and F. Bernardi
Modulation of Factor V Levels in Plasma by Polymorphisms in the C2 Domain
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2004;
24(1):
200 - 206.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. G. Mann and M. Kalafatis
Factor V: a combination of Dr Jekyll and Mr Hyde
Blood,
January 1, 2003;
101(1):
20 - 30.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Soria, L. Almasy, J. C. Souto, A. Buil, E. Martinez-Sanchez, J. Mateo, M. Borrell, W. H. Stone, M. Lathrop, J. Fontcuberta, et al.
A new locus on chromosome 18 that influences normal variation in activated protein C resistance phenotype and factor VIII activity and its relation to thrombosis susceptibility
Blood,
January 1, 2003;
101(1):
163 - 167.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Yamazaki, G. A. F. Nicolaes, K. W. Sorensen, and B. Dahlback
Molecular basis of quantitative factor V deficiency associated with factor V R2 haplotype
Blood,
September 18, 2002;
100(7):
2515 - 2521.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. R. Folsom, M. Cushman, M. Y. Tsai, N. Aleksic, S. R. Heckbert, L. L. Boland, A. W. Tsai, N. D. Yanez, and W. D. Rosamond
A prospective study of venous thromboembolism in relation to factor V Leiden and related factors
Blood,
April 15, 2002;
99(8):
2720 - 2725.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. A.F. Nicolaes and B. Dahlback
Factor V and Thrombotic Disease: Description of a Janus-Faced Protein
Arterioscler. Thromb. Vasc. Biol.,
April 1, 2002;
22(4):
530 - 538.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Pastinen, M. Perola, J. Ignatius, C. Sabatti, P. Tainola, M. Levander, A.-C. Syvanen, and L. Peltonen
Dissecting a population genome for targeted screening of disease mutations
Hum. Mol. Genet.,
December 1, 2001;
10(26):
2961 - 2972.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Dragoni, D. Tormene, P. Simioni, P. Arcieri, G. Avvisati, and A. Girolami
ProC Global: A New Automated Screening Assay for the Evaluation of Total Function of the Protein C System
Clinical and Applied Thrombosis/Hemostasis,
October 1, 2001;
7(4):
351 - 355.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Kalafatis, P. Simioni, and F. Bernardi
Phenotype and genotype expression in pseudohomozygous R2 factor V
Blood,
September 15, 2001;
98(6):
1988 - 1990.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T C F Sykes, C Fegan, and D Mosquera
Thrombophilia, polymorphisms, and vascular disease
Mol. Pathol.,
December 1, 2000;
53(6):
300 - 306.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
E. Castoldi, P. Simioni, M. Kalafatis, B. Lunghi, D. Tormene, D. Girelli, A. Girolami, and F. Bernardi
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family
Blood,
August 15, 2000;
96(4):
1443 - 1448.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Arnaud, V. Barbalat, V. Nicaud, F. Cambien, A. Evans, C. Morrison, D. Arveiler, G. Luc, J.-B. Ruidavets, J. Emmerich, et al.
Polymorphisms in the 5' Regulatory Region of the Tissue Factor Gene and the Risk of Myocardial Infarction and Venous Thromboembolism : The ECTIM and PATHROS Studies
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2000;
20(3):
892 - 898.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Lane and P. J. Grant
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease
Blood,
March 1, 2000;
95(5):
1517 - 1532.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E.M. Faioni, F. Franchi, P. Bucciarelli, M. Margaglione, V. De Stefano, G. Castaman, G. Finazzi, and P.M. Mannucci
Coinheritance of the HR2 Haplotype in the Factor V Gene Confers an Increased Risk of Venous Thromboembolism to Carriers of Factor V R506Q (Factor V Leiden)
Blood,
November 1, 1999;
94(9):
3062 - 3066.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Mitsiev, S. Reinhold, S. Ziemer, H.-H. Neumayer, and B. Hocher
Combination of APC resistance and acquired protein S deficiency in a haemodialysis patient with recurrent A-V shunt thrombosis
Nephrol. Dial. Transplant.,
October 1, 1999;
14(10):
2474 - 2477.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Zivelin, S. Gitel, J. H. Griffin, X. Xu, J. A. Fernandez, U. Martinowitz, Y. Cohen, H. Halkin, U. Seligsohn, and A. Inbal
Extensive Venous and Arterial Thrombosis Associated With an Inhibitor to Activated Protein C
Blood,
August 1, 1999;
94(3):
895 - 901.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. C.H. de Visser, F. R. Rosendaal, and R. M. Bertina
A Reduced Sensitivity for Activated Protein C in the Absence of Factor V Leiden Increases the Risk of Venous Thrombosis
Blood,
February 15, 1999;
93(4):
1271 - 1276.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kalafatis, F. Bernardi, P. Simioni, B. Lunghi, A. Girolami, and K. G. Mann
Phenotype and Genotype Expression in Pseudohomozygous Factor VLEIDEN : The Need for Phenotype Analysis
Arterioscler. Thromb. Vasc. Biol.,
February 1, 1999;
19(2):
336 - 342.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Lunghi, E. Castoldi, F. Mingozzi, F. Bernardi, and G. Castaman
A Novel Factor V Null Mutation Detected in a Thrombophilic Patient With Pseudo-Homozygous APC Resistance and in an Asymptomatic Unrelated Subject
Blood,
August 15, 1998;
92(4):
1463 - 1465.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Williamson, K. Brown, R. Luddington, C. Baglin, and T. Baglin
Factor V Cambridge: A New Mutation (Arg306right-arrowThr) Associated With Resistance to Activated Protein C
Blood,
February 15, 1998;
91(4):
1140 - 1144.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Lunghi, E. Castoldi, F. Mingozzi, and F. Bernardi
A New Factor V Gene Polymorphism (His 1254 Arg) Present in Subjects of African Origin Mimics the R2 Polymorphism (His 1299 Arg)
Blood,
January 1, 1998;
91(1):
364 - 365.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. A.F. Nicolaes and B. Dahlback
Factor V and Thrombotic Disease: Description of a Janus-Faced Protein
Arterioscler. Thromb. Vasc. Biol.,
April 1, 2002;
22(4):
530 - 538.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
